Carbohydrate Phosphinites in Asymmetric Catalysis
J . Org. Chem., Vol. 62, No. 17, 1997 6025
A Typ ica l P r oced u r e for t h e Syn t h esis of a Dia r yl-
p h osp h in ite.12 To a solution of 300 mg (0.75 mmol) of methyl
2,6-O-dibenzoyl-R-D-glucopyranoside and 10 mg of DMAP in
5 mL of pyridine was added 430 mg (1.56 mmol) of bis(3,5-
dimethylphenyl)chlorophosphine in 5 mL of CH2Cl2. After 16
h, the mixture was concentrated to dryness. Benzene was
added to the residue, and this mixture was filtered and
concentrated. Recrystallization from hexane/benzene gave 600
mg (91%) of 20b: 1H NMR 1.73 (s, 6 H), 1.88 (s, 6 H), 1.91 (s,
6 H), 2.02 (s, 6 H), 2.75 (s, 3 H), 3.90 (dd, J ) 4, 12, 1 H), 4.04
(dd, J ) 4, 10, 1 H), 4.42 (d, J ) 12, 1 H), 4.89 (m, 1 H), 5.00
(d, J ) 3, 1 H), 5.23 (m, 1 H), 5.51 (dd, J ) 4, 10, 1 H), 6.03 (s,
1 H), 6.32 (s, 1 H), 6.46 (s, 1 H), 6.63 (s, 1 H), 6.70-7.30 (m,
aromatic), 7.80 (m, aromatic), 8.13 (m, aromatic); 31P NMR
124.7, 118.8. Anal. C 72.30; H 6.82; P 6.58. Calcd for
C53H56O8P2: C 72.10; H 6.39; P 7.02.
[(11g)Rh (COD)]+ BF 4-. (C6D6) νA ) 122.9, νB ) 126.8, J PP
) 39 , J RhP ) 179. Minor component (30%) νA ) 123.9, νB
139.9, J PP ) 48, J RhP1 ) 234, J RhP2 ) 240.
)
[(11g)Rh (COD)]+ OTf-. (C6D6) νA ) 122.4, νB ) 125.9, J PP
) 44 , J RhP ) 180.
-
[(11h )Rh (COD)]+ BF 4
.
31P NMR (C6D6): νA ) 125.0, νB
) 117.3, J PP ) 36 Hz, J RhP ) 173.
Met h yl 4,6-O-Ben zylid en e-2,3-b is-O-[b is(3,5-d im et h -
ylph en yl)ph osph in o]-r-D-glu copyr an oside. 1H NMR 7.34-
6.42 (m, aromatic), 5.13 (s, 1 H), 5.03 (m, 1 H), 4.49-4.42 (m,
2 H), 4.02 (dd, J ) 5, 10, 1 H), 3.88 (m, 1 H), 3.56 (t, J ) 9, 1
H), 3.37 (t, J ) 10, 1 H), 2.75 (s, 3 H), 1.95 (s, 6 H), 1.94 (s, 6
H), 1.91 (s, 6 H), 1.90 (s, 6 H); 31P NMR 119.6, 118.9.
Liga n d s a n d Ca ta lysts fr om Meth yl 2,6-Di-O-ben zoyl-
r-D-glu cop yr a n osid e (18).
P r ep a r a tion of Rh -Com p lexes: Gen er a l P r oced u r e. In
a dry box under nitrogen, a solution of 0.50 mmol of phos-
phinite in 5 mL of CH2Cl2 was added to 0.49 mmol of
+
Rh(COD)2 X- (X ) SbF6, BF4, OSO2CF3) in 5 mL of CH2Cl2
at room temperature. The mixture was stirred for 30 min to
3 h and the solvent was carefully removed under vacuum. A
fine powder of the Rh-complex may be obtained by redissolving
the complex in 8 mL of benzene and freeze-drying the sample
under high vacuum.
Ligan ds an d Catalysts fr om P h en yl 4,6-O-Ben zyliden e-
â-D-glu cop yr a n osid e (10).
Met h yl 2,6-Di-O-b en zoyl-3,4-b is-O-[b is(3,5-d im et h yl-
p h en yl)p h osp h in o]-r-D-glu cop yr a n osid e (20b) (for prepa-
ration see Typical Procedure for the Synthesis of a Phosphin-
ite).
-
[(20b)Rh (COD)]+ BF 4
.
31P NMR (C6D6): ABX () P1P2Rh),
νA ) 129.0, νB ) 130.4, J PP ) 10, J AX ) J BX () J RhP) ) 175.
-
[(20b)Rh (COD)]+ SbF6
.
31P NMR (C6D6): ABX () P1P2Rh),
νA ) 132.8, νB ) 134.2, J PP ) 30, J AX ) J BX () J RhP) ) 151.
[(20b)Rh (COD)]+ OTf-. 31P NMR (C6D6): ABX () P1P2Rh),
νA ) 130.5, νB ) 131.8, J PP ) 34, J AX ) J BX () J RhP) ) 174.
Meth yl 2,6-Di-O-ben zoyl-3,4-bis-O-[bis(4-m eth oxyph en -
yl)p h osp h in o]-r-D-glu cop yr a n osid e (20c). 1H NMR 3.02
(s, 3 H), 3.19 (s, 3 H), 3.32 (s, 3 H), 3.34 (s, 3 H), 3.41 (s, 3 H),
4.19 (m, 1 H), 4.29 (m, 1 H), 4.65 (dd, J ) 2, 12, 1 H), 4.93 (m,
1 H), 5.27 (d, J ) 4, 1 H), 5.45 (m, 1 H), 5.69 (dd, J ) 4, 10, 1
H), 6.46-8.40 (m, aromatic); 31P NMR 120.5 (d, 1, J PP ) 5),
117.8 (d, 1, J PP ) 5). Anal. C, 65.33; H, 5.58; P 6.99. Calcd
P h en yl 4,6-O-ben zylid en e-2,3-bis-O-(d ia r ylp h osp h in o)-
â-D-glu cop yr a n osid es (11a -11h ). The synthesis of these
ligands and their spectral properties have been described
elsewhere.12
-
[(11a )Rh (COD)]+ SbF 6
.
31P NMR (C6D6) ABX () P1P2Rh),
νA ) 129.9, νB ) 131.3, J PP ) 24, J RhP ) 176.
for C49H48O12P2 C 66.06; H 5.43; P 6.95.
-
[(11a )Rh (COD)]+ BF 4
.
31P NMR (C6D6) ABX () P1P2Rh),
-
[(20c)Rh (COD)]+ BF 4
.
31P NMR (C6D6): ABX () P1P2Rh),
νA ) 125.6, νB ) 128.3, J PP ) 38, J AX ) J BX () J RhP) ) 175.
νA ) 134.4, νB ) 136.1, J PP ) 28, J AX ) J BX () J RhP) ) 181 Hz.
Meth yl 2,6-Di-O-ben zoyl-3,4-bis-O-(diph en ylph osph in o)-
r-D-glu cop yr a n osid e (20e). 1H NMR 2.78 (s, 3 H), 3.91 (dd,
J ) 4, 12, 1 H), 4.04 (dd, J ) 4, 10, 1 H), 4.39 (d, J ) 12, 1 H),
4.70 (m, 1 H), 5.08 (d, J ) 3, 1 H), 5.22 (m, 1 H), 5.40 (dd, J )
4, 12, 1 H), 6.49-7.50 (m, aromatic), 7.85 (m, 2 H, aromatic),
8.12 (m, 2 H, aromatic); 31P NMR 120.0 (d, J PP ) 4), 116.0 (d,
-
[(11b)Rh (COD)]+ SbF 6
.
31P NMR (CDCl3): ABX ()
P1P2Rh), νA ) 136.6, νB ) 136.8, J PP ) 27, J AX ) J BX () J RhP
)
) 177; in C6D6 ABX () P1P2Rh), νA ) 134.0, νB ) 136.0, J PP
)
29, J AX ) J BX () J RhP) ) 175.
-
[(11b )R h (COD)]+ BF 4
.
31P NMR (CDCl3): ABX ()
P1P2Rh), νA ) 133.6. νB ) 129.3, J PP ) 31, J AX ) J BX () J RhP
)
J PP ) 4).
) 177.
-
[(20e)Rh (COD)]+ BF 4
.
31P NMR (C6D6): ABX () P1P2Rh),
-
[(11c)Rh (COD)]+ SbF 6
.
31P NMR (C6D6) ABX () P1P2Rh),
νA ) 130.8, νB ) 133.7, J PP ) 32, J AX ) J BX () J RhP) ) 176.
νA ) 139.5, νB ) 140.1, J PP ) 24 , J AX ) J BX () J RhP) ) 182.
-
[(20e)Rh (COD)]+ SbF6
.
31P NMR (C6D6): ABX () P1P2Rh),
[[(11c)Rh (COD)]+ OTf -
.
31P NMR (C6D6) ABX () P1P2Rh),
νA ) 136.3, νB ) 133.1, J PP ) 28 Hz, J AX ) J BX () J RhP) ) 177
Hz.
νA ) 136.8, νB ) 138.5, J PP ) 28 , J AX ) J BX () J RhP) ) 181.
-
[(11d )Rh (COD)]+ SbF 6
.
31P NMR (CDCl3): ABX ()
Meth yl 2,6-Di-O-ben zoyl-3,4-bis-O-[bis(3,5-diflu or oph en -
yl)p h osp h in o]-r-D-glu cop yr a n osid e (20f). 1H NMR 2.81
(s, 3 H), 3.86 (m, 2 H), 4.23 (m, 1 H), 4.46 (m, 1 H), 4.82 (m, 1
H), 4.99 (d, 1, 4 H), 5.24 (dd, J ) 4, 10, 1 H), 5.71 (m, 1 H),
6.10-6.34 (m, 3 H), 6.58-8.20 (m, aromatic); 31P NMR 113.3,
P1P2Rh), νA ) 134.7, νB ) 137.9, J PP ) 28, J AX ) J BX ()J RhP) )
182.
-
[(11d )Rh (COD)]+ BF 4
. (CDCl3) ABX () P1P2Rh), νA )
131.4, νB ) 135.9, J PP ) 30, J AX ) J BX () J RhP) ) 180.
-
[(11e)Rh (COD)]+ SbF 6
.
31P NMR (CDCl3): ABX ()
109.8.
P1P2Rh), νA ) 137.5, νB ) 138.6, J AB ) 27, J AX ) J BX ()J RhP
)
-
[(20f)Rh (COD)]+ BF 4
.
31P NMR (C6D6): ABX () P1P2Rh),
) 176.
νA ) 126.7, νB ) 127.6, J PP ) 39, J AX ) J BX () J RhP) ) 179.
Meth yl 2,6-Di-O-ben zoyl-3,4-bis-O-[bis[3,5-bis(tr iflu o-
r om eth yl)p h en yl]p h osp h in o]-r-D-glu cop yr a n osid e (20g).
1H NMR 2.93 (s, 3 H), 3.98 (dd, J ) 5 12, 1 H), 4.11 (dd, J )
5, 10, 1 H), 4.28 (d, J ) 12, 1 H), 4.52 (m, 1 H), 5.11 (d, J ) 4,
1 H), 5.19 (m, 1 H), 5.45 (dd, J ) 4, 10, 1 H), 6.89-8.22 (m,
aromatic), 31P NMR 113.0, 107.5. Anal. C 48.38; H, 2.79; P
-
[(11e)Rh (COD)]+ BF 4
. )
31P NMR: ABX () P1P2Rh), νA
134.6,νB ) 137.5, J PP ) 28, J AX ) J BX () J RhP) ) 179.
-
[(11f)Rh (COD)]+ SbF 6
.
31P NMR (CDCl3): multiplet
superimposed on an ABX 8-line pattern with further small
coupling presumably due to long range interaction with
fluorines. δ 126.5, 126.8, 128.0, 128.3, 129.2, 129.5, 130.8,
131.1 (insoluble in benzene).
4.65. Calcd for C53H32F24O8P2 C, 48.42; H, 2.45; P 4.71.
-
[(11f)Rh (COD)]+ BF 4
. )
31P NMR: ABX () P1P2Rh), νA
-
[(20g)Rh (COD)]+ BF 4
.
31P NMR (C6D6/CD2Cl2): 127.6 (d,
125.4, νB ) 120.3, J AB ) 38, J AX ) J BX () J RhP) ) 179.
J RhP ) 181).
-
[(11g)Rh (COD)]+ SbF6
.
31P NMR (C6D6): ABX () P1P2Rh),
Met h yl 2,6-Di-O-b en zoyl-3,4-b is-O-[b is[4-(t r iflu or o-
m eth yl)p h en yl]p h osp h in o]-r-D-glu cop yr a n osid e (20h ).
1H NMR (C6D6) 2.80 (s, 3 H), 3.85 (dd, J ) 13, 4, 1 H), 4.06
(ddm, J ) 8, 4, 1 H), 4.28 (dd, J ) 13, 2, 1 H), 4.60 (dt, J ) 12,
12 1 H), 5.00 (m, 1 H), 5.03 (d, J ) 4, 1 H), 5.28 (dd, 12, 4, 1
H), 6.70-7.60 (m, aromatic). Anal. Calcd for C49H36F12O8P2
C 56.44; H 3.48; P 5.94. Found C 56.36; H 3.75; P 5.92.
νA ) 126.8, νB ) 130.5, J PP ) 36, J AX ) J BX () J RhP) ) 182. In
addition this complex shows another minor component (10-
15%) with similar 8-line 31P spectrum. Seven of these lines
appear at δ 124.2, 124.6, 126.5, 138.4, 138.8, 140.3, and 140.7.
The 8th line could not be located. It is possibly under the peak
at 126.1.